GFAFX
Price
$86.82
Change
+$0.47 (+0.54%)
Updated
Sep 11 closing price
Net Assets
353.07B
WPASX
Price
$47.57
Change
+$0.76 (+1.62%)
Updated
Sep 11 closing price
Net Assets
421.64M
Interact to see
Advertisement

GFAFX vs WPASX

GFAFX vs WPASX Comparison Chart in %
View a ticker or compare two or three
VS
GFAFX vs. WPASX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a Buy and WPASX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 353B vs. WPASX (422M). GFAFX pays higher dividends than WPASX: GFAFX (0.20) vs WPASX (0.00). GFAFX was incepted earlier than WPASX: GFAFX (26 years) vs WPASX (13 years). WPASX (1.00) is less costly to investors than GFAFX (0.65). GFAFX is a more actively managed with annual turnover of: 32.00 vs. WPASX (18.00). GFAFX has a lower initial minimum investment than WPASX: GFAFX (250) vs WPASX (2500). GFAFX annual gain was more profitable for investors over the last year : 0.02 vs. WPASX (-15.44). GFAFX return over 5 years is better than : 13.04 vs. WPASX (-23.32).
GFAFXWPASXGFAFX / WPASX
Total Expense Ratio0.651.0065%
Annual Report Gross Expense Ratio0.651.0065%
Fund Existence26 years13 years-
Gain YTD9.043-6.268-144%
Front LoadN/A4%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets353B422M83,649%
Annual Yield % from dividends0.200.00-
Returns for 1 year0.02-15.44-0%
Returns for 3 years42.74-3.84-1,112%
Returns for 5 years13.04-23.32-56%
Returns for 10 years106.2570.15151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAMS22.800.94
+4.30%
NewAmsterdam Pharma Company NV
BYRN3.620.09
+2.55%
Byrna Technologies
CX10.690.03
+0.28%
Cemex SAB de CV
RGNX8.53-0.03
-0.35%
REGENXBIO
CRIS1.13-0.03
-2.59%
Curis Inc.